Xcout Intel
Novadip competitors & alternatives
The 12 closest competitors and alternatives to Novadip among biotechnology companies — ranked by similarity to what Novadip actually does, not by market-cap band.
Subscribe to see Novadip’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Novadip
Novadip Biosciences is a clinical-stage biopharmaceutical company founded in 2013 and headquartered in Belgium, focusing on innovative tissue regeneration and biopharmaceuticals.
Novadip at a glance
Novadip is a biotechnology company headquartered in Belgium. It has raised at least $61.2M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $39.1M in November 2022. Xcout tracks 15 named people at Novadip, including Soumya Chandramouli (Chief Financial Officer).
Novadip leadership
- Soumya ChandramouliChief Financial Officer
- Neil JohnsonChief Technology Officer
- Judy AshworthChief Medical Officer
- Siegfried EbnerChief Operations Officer
- Denis DufraneCo-Founder, Chief Executive Officer & Board Member
- Gaëtane MetzVP Quality-EHS
9 more named people on record for Novadip, with roles, board committees and tenure — see the full roster →
Novadip funding rounds
At least $61.2M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $39.1M | — | |
| — | $22.1M | 9 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Novadip competitors
Ranked by semantic similarity — how close each company is to Novadip by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Endogena Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Zürich, Switzerland, that discovers and develops first-in-class endogenous regenerative medicines to repair tissues.
Similar biotechnology company
NovaGo Therapeutics is a clinical-stage Swiss biotech company located in Schlieren that develops human antibody therapeutics focused on nerve growth and regeneration.
Similar biotechnology company
Celyad Oncology is a biopharmaceutical company headquartered in Mont-Saint-Guibert, Belgium, focused on the development of innovative therapies.
Similar biotechnology company
Kadimastem Ltd. is a clinical-stage cell therapy company headquartered in Ness Ziona, Israel, focused on developing advanced cell-based therapeutic treatments.
Similar biotechnology company
Vaderis Therapeutics AG is a clinical-stage biotechnology company focused on developing novel treatments for severe vascular diseases. The company is headquartered in Basel, Switzerland.
Similar biotechnology company
Eluciderm Inc. is a clinical-stage regenerative medicine small-molecule pharmaceutical company that uses a selective multi-PARP modulation platform to alter the body’s response to inflammation and injury. The company develops therapeutics designed to enable organized tissue regeneration, enhance wound healing, and minimize scarring following trauma.
Life Sciences
NED Biosystems, Inc. is a clinical-stage biotechnology company founded to allow patients to achieve and sustain no evidence of disease across a broad range of conditions.
Similar biotechnology company
Cellics Therapeutics, Inc. is a privately held biotechnology company headquartered in San Diego, California, developing novel therapeutic products.
Similar biotechnology company
Rejuvenate Biomed is an independent research and development biotechnology company spun out from the Janssen Pharmaceutical companies of Johnson & Johnson. Headquartered in Diepenbeek in the Flemish Region of Belgium, the company focuses on longevity research to keep people healthy longer. It also maintains a presence in Cambridge, Massachusetts.
Similar biotechnology company
Imagine Pharma LLC is a biotechnology company that develops novel polypeptide-based platforms focused on oral delivery for biologic drugs, therapeutics for various disease states, and regenerative medicine. The company aims to create first-in-class treatments for conditions such as diabetes and wound healing, alongside offering oral peptide dietary supplements and functional ingredients for consumers.
Similar biotechnology company
NX PharmaGen Inc. is a biotechnology company headquartered in Louisville, Kentucky, focused on groundbreaking scientific technologies and cell processing.
Biotech
Aspect Biosystems develops bioengineered cellular medicines and implantable tissue therapeutics using a proprietary bioprinting platform that integrates AI, computational design, and advanced biomaterials. The company serves the biotechnology and pharmaceutical industries by creating treatments to replace, repair, or supplement biological functions for metabolic and endocrine diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Novadip and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Novadipand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →